Clinical Trial Update: THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence [NA]

View source ↗

Summary

The THRIVE study evaluating Positive Affect Training to improve adherence to endocrine therapy in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: Joanna Arch | Conditions: Breast Cancer, DCIS | NA | Status: COMPLETED